Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion

As vaccination programs help reduce severe acute respiratory syndrome transmission coronavirus 2019 (SARS-CoV-2), one of the remaining concerns is the spread of variants of concern (VOCs). These variants are known to evade immune responses effective against the original strain found in Wuhan, China.

Study: Spike Protein NTD mutation G142D in SARS-CoV-2 Delta VOC lineages is associated with frequent back mutations, increased viral loads, and immune evasion. Image Credit: Corona Borealis Studio/ ShutterstockStudy: Spike Protein NTD mutation G142D in SARS-CoV-2 Delta VOC lineages is associated with frequent back mutations, increased viral loads, and immune evasion. Image Credit: Corona Borealis Studio/ Shutterstock

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Of particular concern is the Delta variant, which arose in India to quickly become the most dominant strain worldwide. Most VOCs have mutations that affect the spike protein of SARS-CoV-2, especially the receptor-binding domain (RBD) of the S1 subunit, as this is the area that binds to angiotensin-converting enzyme 2 (ACE2), allowing membrane fusion and viral entry into the cell.

To further explore the Delta variant's increased transmission, viral load, and pathogenicity, researchers from the University of Southern California investigated mutations in the N-terminal and RBD domains of the spike protein.

A preprint version of the study is available on the medRxiv* server while the article undergoes peer review.

The study

The scientists used reverse-transcriptase polymerase chain reaction (RT-PCR) to confirm the previous infection of samples from the Children's Hospital Los Angeles before sequencing the whole genome of the samples and analyzing the phylogenetics and structure of the mutated strains. The final dataset was formed from over 15,000 SARS-CoV-2 genomes, but only ~12,500 were included in the phylogenetic analysis due to quality worries.

They found that initially, the Delta variant showed far fewer spike protein mutations than other variants – an average of 9.66-10.12 missense mutations per genome. However, Delta variant lineages showed a far faster increase in mutations per genome for the gene encoding the spike protein and genes ORF7a and ORF7b.

As well as this, mutation Spike G142D was present in almost all major Delta sub-lineages. This mutation was likely incorporated in late September 2020 and spread to most other major branches by November. Other mutations, such as T951, did not show the same pattern. Both G14D2 and T951 are associated with higher viral loads when an individual is infected with a Delta variant of SARS-CoV-2. It is thought when these two mutations are both present, a conversion of a beta-strand to an alpha-helix changes the structure of the spike proteins N-terminal domain.

The group's findings are supported by previous studies, which show that neutralizing antibodies produced against the N-terminal domain are effective against the original strain of SARS-CoV-2 lose their efficiency against the Delta strain. The change in surface topography exposes new antibody-facing residues, likely to reduce antibody binding to this region. While both the T951 and the G142D mutations alter the structure of this region, G142D appears to induce the most significant change.

The G142D mutation appears to have been repeatedly gained, lost, and regained across multiple Delta lineages. It appears that the random RNA polymerase errors widely seen in SARS-CoV-2 cannot be completely responsible. The hallmarks of RNA editing are clear – adenosine to inosine changes and cytosine to uracil changes indicate that APOBEC deaminases and ADAR proteins (which both play a role in host immunity) could be the underlying cause behind these mutations. Thus, the host immune response could be responsible for the heterogeneity seen in the SARS-CoV-2 genome. It is already thought that this could cause the D614G mutation that is present in all Delta strain variants.

Conclusion

The authors propose that Delta variants with the mutation G142D altering the conformation of the spike protein N-terminal domain lead to reduced binding of neutralizing antibodies. The presence of the T951 mutation exacerbates this effect.

The structural change reduces the effectiveness of the neutralizing antibody by presenting alternate residues on the N-terminal domain epitope – a common target for antibodies- which increases viral loads for the host and could be a large factor in the increased transmission rates of the Delta variant.

The researchers highlight the concerning increased frequency of spike protein mutations and raise awareness of the worrying evolutionary trajectory of SARS-CoV-2; If more mutations arise that change the structure of the N-terminal domain, or even the RBD, then the rates of reinfection and vaccine/immunity evasion could rise dramatically.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
  • Preliminary scientific report. Shen, L. et al. (2021) "Spike Protein NTD mutation G142D in SARS-CoV-2 Delta VOC lineages is associated with frequent back mutations, increased viral loads, and immune evasion". medRxiv. doi: 10.1101/2021.09.12.21263475.
Sam Hancock

Written by

Sam Hancock

Sam completed his MSci in Genetics at the University of Nottingham in 2019, fuelled initially by an interest in genetic ageing. As part of his degree, he also investigated the role of rnh genes in originless replication in archaea.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hancock, Sam. (2023, April 29). Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion. News-Medical. Retrieved on October 09, 2024 from https://www.news-medical.net/news/20210920/Novel-spike-NTD-mutations-in-SARS-CoV-2-Delta-variant-associated-with-increased-viral-loads-and-immune-evasion.aspx.

  • MLA

    Hancock, Sam. "Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion". News-Medical. 09 October 2024. <https://www.news-medical.net/news/20210920/Novel-spike-NTD-mutations-in-SARS-CoV-2-Delta-variant-associated-with-increased-viral-loads-and-immune-evasion.aspx>.

  • Chicago

    Hancock, Sam. "Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion". News-Medical. https://www.news-medical.net/news/20210920/Novel-spike-NTD-mutations-in-SARS-CoV-2-Delta-variant-associated-with-increased-viral-loads-and-immune-evasion.aspx. (accessed October 09, 2024).

  • Harvard

    Hancock, Sam. 2023. Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion. News-Medical, viewed 09 October 2024, https://www.news-medical.net/news/20210920/Novel-spike-NTD-mutations-in-SARS-CoV-2-Delta-variant-associated-with-increased-viral-loads-and-immune-evasion.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lithium aspartate fails to improve long COVID symptoms, but higher doses may hold promise